Health-Holland

Oncode is a new independent world-class, innovative institute that unites, under a common strategy, more than five hundred of the Netherlands' most outstanding scientists, specialized in the field of fundamental oncological research (i.e. research on how cancer operates at a basic, molecular level). Oncode incorporates the knowledge and experience to identify and foster scientific discoveries that are potentially beneficial to patients. The institute helps to pave the path leading from such discoveries towards translational and clinical research and practical applications. Outsmarting cancer, Impacting lives. www.oncode.nl Health-RI connects existing Dutch Infrastructure programs in a public-private partnership. Health-RI builds a state-of-the-art infrastructure to support personalized medicine and health research in the Netherlands. The national infrastructure improves efficiency by offering shared services, allowing for optimal exchange and reuse of data, samples and images, and acting as the collective voice of the field for research infrastructure related topics. By optimally facilitating personalized medicine and health research, Health-RI will accelerate the development of personalized medicine and health solutions, creating major value for researchers, patients and citizens. www.health-ri.nl RegMed XB (Regenerative Medicine Crossing Borders) is a virtual institute that uses regenerative medicine strategies to cure common chronic diseases. It comprises an intensive Flemish-Dutch public-private partnership between governments, health funds, doctors, scientists and specialized companies. In phase 1, the ambitious research focuses on curing patients with type 1 diabetes, kidney failure and osteoarthritis. Looking to the future, the research will also focus on other diseases.  Regenerative Medicine holds the promise to cure many of what are now chronic patients, restoring health rather than protracting decline, bettering the lives of millions in the Netherlands and beyond and at the same time preventing lifelong, expensive care processes:  Cure instead of Care. www.regmedxb.com An enabling mechanism There are currently around 200 PPPs in the Netherlands, of varying shapes and sizes, working together to find answers to many of society’s healthcare challenges. These diverse partnerships are able to share funding as well as the bundled knowledge and expertise of the various participants. This is crucial in the biopharmaceutical sector as it creates opportunities for the joint-development of medicines for complex diseases. PPPs often enable medicines and vaccines to be developed more rapidly, in the drive to cure destructive diseases such as Alzheimer’s, anti-microbial resistance, and cancer. Below are some recent examples of Dutch public-private partnerships in the field of Life Sciences and Health. 17